Re: The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA): A population‐based case–control study.

The article discusses a study on the risk of psychiatric disorders in individuals using finasteride for benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA). The study methodology is described as a retrospective cohort study rather than a case-control study, with concerns raised about the choice of controls impacting the study's conclusions. The authors emphasize the importance of accurately identifying and reporting study methodologies to avoid confusion and bias in research findings. The article highlights the need for thorough assessment and reporting of study methodologies to ensure confidence in research outcomes. [Extracted from the article]